Une nouvelle classe de médicaments abortifs (gépants) a été approuvée par la FDA aux USA. Il s’agit d’un inhibiteur oral du peptide associé au gène de la calcitonine (CGRP).
What You Need to Know About Ubrelvy, First Acute CGRP Med Approved – Migraine Again
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP inhibitor – the first of its kind to be approved.